These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35068114)

  • 41. Pulse oximetry screening for critical congenital heart disease in planned out of hospital births and the incidence of critical congenital heart disease in the Plain community.
    Miller KK; Vig KS; Goetz EM; Spicer G; Yang AJ; Hokanson JS
    J Perinatol; 2016 Dec; 36(12):1088-1091. PubMed ID: 27583398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oximetry and neonatal examination for the detection of critical congenital heart disease: a systematic review and meta-analysis.
    Aranguren Bello HC; Londoño Trujillo D; Troncoso Moreno GA; Dominguez Torres MT; Taborda Restrepo A; Fonseca A; Sandoval Reyes N; Chamorro CL; Dennis Verano RJ
    F1000Res; 2019; 8():242. PubMed ID: 31372214
    [No Abstract]   [Full Text] [Related]  

  • 43. Pulse Oximetry Screening and Critical Congenital Heart Disease in the State of Oregon.
    Cave AT; Lowenstein SA; McBride C; Michaud J; Madriago EJ; Ronai C
    Clin Pediatr (Phila); 2021 Jun; 60(6-7):290-297. PubMed ID: 33855884
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a Newborn Screening Program for Critical Congenital Heart Disease (CCHD) in Taipei.
    Tsao PC; Shiau YS; Chiang SH; Ho HC; Liu YL; Chung YF; Lin LJ; Chen MR; Chang JK; Soong WJ; Lin HL; Hwang B; Hsiao KJ
    PLoS One; 2016; 11(4):e0153407. PubMed ID: 27073996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prevalence, mortality and lethality of congenital heart defects from the Tuscan Registry (Tuscany Region, Central Italy), 1992-2009].
    Baldacci S; Pierini A; Santoro M; Spadoni I; Bianchi F
    Epidemiol Prev; 2015; 39(1):36-44. PubMed ID: 25855545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Congenital Heart Disease Prevalence in Portugal in 2015: Data from the National Register of Congenital Anomalies].
    Melo IS; Braz P; Roquette R; Sousa P; Nunes C; Dias C
    Acta Med Port; 2020 Jul; 33(7-8):491-499. PubMed ID: 32669188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparing risk factors associated with the late detection of critical congenital heart disease at different facility levels.
    Sotodate G; Oyama K; Saiki H; Matsumoto A; Konishi Y; Toya Y; Takashimizu N; Tsuchiya S
    J Obstet Gynaecol Res; 2021 Mar; 47(3):961-967. PubMed ID: 33350039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paper 2: EUROCAT public health indicators for congenital anomalies in Europe.
    Khoshnood B; Greenlees R; Loane M; Dolk H; ;
    Birth Defects Res A Clin Mol Teratol; 2011 Mar; 91 Suppl 1(Suppl 1):S16-22. PubMed ID: 21381186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease.
    Peterson C; Grosse SD; Glidewell J; Garg LF; Van Naarden Braun K; Knapp MM; Beres LM; Hinton CF; Olney RS; Cassell CH
    Public Health Rep; 2014; 129(1):86-93. PubMed ID: 24381364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Critical congenital heart disease screening practices among licensed midwives in washington state.
    Evers PD; Vernon MM; Schultz AH
    J Midwifery Womens Health; 2015; 60(2):206-10. PubMed ID: 25782853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of a Screening Program to Detect Critical Congenital Heart Defects in Newborns.
    Klausner R; Shapiro ED; Elder RW; Colson E; Loyal J
    Hosp Pediatr; 2017 Apr; 7(4):214-218. PubMed ID: 28250095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multilevel analyses of related public health indicators: The European Surveillance of Congenital Anomalies (EUROCAT) Public Health Indicators.
    Best KE; Rankin J; Dolk H; Loane M; Haeusler M; Nelen V; Verellen-Dumoulin C; Garne E; Sayers G; Mullaney C; O'Mahony MT; Gatt M; De Walle H; Klungsoyr K; Carolla OM; Cavero-Carbonell C; Kurinczuk JJ; Draper ES; Tucker D; Wellesley D; Zymak-Zakutnia N; Lelong N; Khoshnood B
    Paediatr Perinat Epidemiol; 2020 Mar; 34(2):122-129. PubMed ID: 32101337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pulse Oximetry Screening for Critical Congenital Heart Defects.
    Wood J
    Neonatal Netw; 2015; 34(3):156-64. PubMed ID: 26802391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease.
    Mahle WT; Martin GR; Beekman RH; Morrow WR;
    Pediatrics; 2012 Jan; 129(1):190-2. PubMed ID: 22201143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulse oximetry screening in Wisconsin.
    Beissel DJ; Goetz EM; Hokanson JS
    Congenit Heart Dis; 2012; 7(5):460-5. PubMed ID: 22494499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adapted protocol for pulse oximetry screening for congenital heart defects in a country with homebirths.
    Narayen IC; Blom NA; Verhart MS; Smit M; Posthumus F; van den Broek AJ; Havers H; Haak MC; te Pas AB
    Eur J Pediatr; 2015 Jan; 174(1):129-32. PubMed ID: 24990493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Texas Pulse Oximetry Project: A Multicenter Educational and Quality Improvement Project for Implementation of Critical Congenital Heart Disease Screening Using Pulse Oximetry.
    Guillory C; Gong A; Livingston J; Creel L; Ocampo E; McKee-Garrett T
    Am J Perinatol; 2017 Jul; 34(9):856-860. PubMed ID: 28264208
    [No Abstract]   [Full Text] [Related]  

  • 58. Rapid implementation of pulse oximetry newborn screening to detect critical congenital heart defects - New Jersey, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Apr; 62(15):292-4. PubMed ID: 23594686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends in Delayed Diagnosis of Critical Congenital Heart Defects in an Era of Enhanced Screening, 2004-2018.
    Liberman RF; Heinke D; Lin AE; Nestoridi E; Jalali M; Markenson GR; Sekhavat S; Yazdy MM
    J Pediatr; 2023 Jun; 257():113366. PubMed ID: 36858148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel, more efficient, staged approach for critical congenital heart disease screening.
    Mouledoux J; Guerra S; Ballweg J; Li Y; Walsh W
    J Perinatol; 2017 Mar; 37(3):288-290. PubMed ID: 27831548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.